Alexander Sparre-Ulrich
Director Ejecutivo en Antag Therapeutics ApS .
Cargos activos de Alexander Sparre-Ulrich
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Antag Therapeutics ApS
 Antag Therapeutics ApS Pharmaceuticals: MajorHealth Technology Antag Therapeutics ApS develops peptide drugs for the treatment of dietary-related metabolic diseases. It develops drugs for obesity, diabetes, and non-alcoholic fatty liver disease. The company was founded by Alexander Sparre-Ulrich and Jens Juul Holst in 2017 and is headquartered in Copenhagen, Denmark. | Director Ejecutivo | 01/01/2017 | - |
| Fundador | 01/01/2017 | - |
Historial de carrera de Alexander Sparre-Ulrich
Estadísticas
Internacional
| Dinamarca | 2 |
Operativa
| Chief Executive Officer | 1 |
| Founder | 1 |
Sectorial
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Antag Therapeutics ApS
Antag Therapeutics ApS Pharmaceuticals: MajorHealth Technology Antag Therapeutics ApS develops peptide drugs for the treatment of dietary-related metabolic diseases. It develops drugs for obesity, diabetes, and non-alcoholic fatty liver disease. The company was founded by Alexander Sparre-Ulrich and Jens Juul Holst in 2017 and is headquartered in Copenhagen, Denmark. | Health Technology |
